PR Newswire - S&E bio Receives Korea's First Approval for Ex...
SEOUL, South Korea, May 1, 2025 /PRNewswire/ -- S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of...
Read More

ภาษาไทย
English